2015 Fall Learning Series - THERAPIES THAT WORK: TRANSLATING THEIR OPTIMAL USE INTO CLINICAL PRACTICE
Our 2015 Fall Learning Series featured three topics on the theme of translating therapies into their the optimal use in clinical practice.
- Secondary Prevention Cocktail: The Key Ingredients; Speaker Alan Brown MD
- Statins and Beyond: New Tools for the Challenging Patient; Speaker Nancy Dagefoerde APN
- Managing VTE: Matching Patient Need to Optimal Therapy; Speaker Heather A. Hall MD
2.25 Credit Hours (1.25 Pharmacology)
Upon completion of the course, participants will be able to:
- Review the secondary prevention guidelines for the post-ACS patient
- List the specific strategies that have proven efficacy for patients at risk for nonadherence
- Describe best practice recommendations for navigating the challenging hospital-to-home transition for the ACS patient
- Describe an evidence-based therapeutic approach to the patient with a true intolerance to statin therapy.
- Outline a treatment plan for the patient who has an inadequate response to high-intensity statin therapy, including strategies to rule out sub-optimal adherence and optimization of patient education
- Describe the integration of shared decision-making into the clinical encounter for a patient with elevated LDL-cholesterol
- Identify prevalence rates of venous thromboembolism (VTE), including rates for morbidity and mortality
- Discuss professional guidelines that stress methods for assessing risk in patients with VTE and provide algorithms for patient management
- Describe methods for ensuring effective communications with patients and caregivers as a means of improving adherence and self-care in patients with VTE